Versant Capital Management, Inc
Position in TEVA — Teva Pharmaceutical Industries Ltd
CIK 1735057
PHOENIX, AZ
Position in TEVA
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$347,778
+$80,735 QoQ
Shares Held
10,265
+15.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#31
of 72 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Versant Capital Management, Inc holds $2,428,042 across 29 Drug Manufacturers - Specialty & Generic names. TEVA ranks #2 (14.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TAK |
Takeda Pharmaceutical Co Ltd
|
42,686 | $684,256 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
10,265 | $347,778 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
9,055 | $222,843 | |
| 4 | VTRS |
Viatris Inc
|
11,789 | $187,209 | |
| 5 | HLN |
Haleon plc
|
16,968 | $158,311 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
737 | $124,213 | |
| 7 | UTHR |
UNITED THERAPEUTICS Corp
|
182 | $98,613 | |
| 8 | ZTS |
Zoetis Inc.
|
1,244 | $89,393 |
All Filings in TEVA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $347,778 | 10,265 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $267,043 | 8,866 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $216,410 | 6,934 | Shares | Sole | 2026-01-08 | |
| 2025-09-30 | $112,312 | 5,560 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $76,744 | 4,579 | Shares | Sole | 2025-07-07 | |
| 2025-03-31 | $81,414 | 5,297 | Shares | Sole | 2025-04-03 | |
| 2024-12-31 | $21,709 | 985 | Shares | Sole | 2025-01-03 | |
| 2024-09-30 | $4,054 | 225 | Shares | Sole | 2024-10-07 | |
| No filing history on record for this holder in this stock. | ||||||